Keywords: Relaxometry, Low-Field MRI, transmemebrane water exchange, cancer invasion/migration, bumetanide drug
Motivation: The transmembrane water exchange (t-Wex) in cancers was demonstrated modulating T1 relaxation at ultra-low field.
Goal(s): Our goal was to demonstrate T1 changes under the administration of drugs that act on cell membrane transports.
Approach: U87 glioma cells sustained H2O2 stimuli before the administration of the bumetanide drug, a NKCC1 inhibitor. T1 changes were measured by FFC-NMR.
Results: At very low field, by comparison to control cells (without H2O2), relaxation rates were found significantly lower under H2O2 stimuli which has been correlated to t-Wex acceleration and higher with the bumetanide addition, that suggests the slowdown of t-Wex.
Impact: Using the bumetanide drug, we show at ultra-low field, the potential of the relaxation T1 as biomarker to evaluate the efficiency of drugs that can target t-Wex, a mechanism that has been connected to cancer invasion/migration pathophysiology
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords